Clinical Trial Update: Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS) [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma and leiomyosarcoma; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dedifferentiated Liposarcoma
• Leiomyosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Afinitor (everolimus) (everolimus)
• Kisqali (ribociclib) (ribociclib)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING